title: Dietary selenium effects on milk eicosanoid concentration in dairy cows during coliform mastitis.
abstract: The effect of selenium deficiency on the product profile of arachidonic acid oxidation by enzymatic pathways in Holstein cows with experimentally-induced coliform mastitis was investigated. The animals were fed dairy rations containing 0.05 mg Se/kg dry matter, with the supplemented group receiving additional Se to increase the dietary concentration to approximately 0.35 mg Se/kg dry matter. Cows were inoculated intracisternally with 30 colony-forming-units of Escherichia coli at 14-16 weeks of lactation. Eicosanoids and bacteria numbers were recorded at various intervals of time for 60 h postinoculation. Milk from cows fed the Se-depleted diet had significantly higher (p less than 0.05) concentrations of TXB2 between 24 and 48 h and 6-keto-PGF1 alpha between 24 and 60 h postinoculation. Milk PGE2 concentration was significantly higher in the Se-deficient group at 24 h, whereas LTB4 was higher between 36 and 60 h postinoculation in the Se-deficient cows (p less than 0.05). Milk bacteria numbers were significantly higher between 16 and 24 h postinoculation in the Se-deficient group and three of the four cows in this group required euthanasia, whereas all four cows in the Se-supplemented group recovered without therapeutic intervention. These data indicate marked effects of dietary Se on milk eicosanoid concentrations in response to an E. coli infection. The changes in eicosanoid concentrations may be associated with the altered pathogenesis and outcome of mastitis in a Se-deficient state.
authors.affiliation: Pennsylvania State University, Department of Veterinary Science, University Park 16802.
authors.forename: J F
authors.initials: JF
authors.lastname: Maddox
authors.forename: C C
authors.initials: CC
authors.lastname: Reddy
authors.forename: R J
authors.initials: RJ
authors.lastname: Eberhart
authors.forename: R W
authors.initials: RW
authors.lastname: Scholz
mesh_terms: D015121:6-Ketoprostaglandin F1 alpha / Q000032:analysis / Q000096:biosynthesis; D000284:Administration, Oral; D000818:Animals; D002417:Cattle; D003677:Deficiency Diseases / Q000150:complications*; D015232:Dinoprostone / Q000032:analysis / Q000096:biosynthesis; D015777:Eicosanoids / Q000032:analysis / Q000096:biosynthesis*; D004927:Escherichia coli Infections / Q000378:metabolism*; D007975:Leukotriene B4 / Q000032:analysis / Q000096:biosynthesis; D008414:Mastitis, Bovine / Q000378:metabolism*; D008892:Milk / Q000378:metabolism*; D012643:Selenium / Q000172:deficiency*; D013929:Thromboxane B2 / Q000032:analysis / Q000096:biosynthesis; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D015777:Eicosanoids; D007975:Leukotriene B4; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D012643:Selenium; D015232:Dinoprostone